Literature DB >> 7468492

Paroxysmal atrial fibrillation in the Wolff-Parkinson-White syndrome.

R A Bauernfeind, C R Wyndham, S P Swiryn, E V Palileo, B Strasberg, W Lam, D Westveer, K M Rosen.   

Abstract

Eighty-eight patients with preexcitation were studied to determine how 30 patients with documented spontaneous paroxysmal atrial fibrillation differed from 58 patients without this arrhythmia. Inducible reentrant tachycardia was present in 23 (77 percent) of the 30 patients with, versus 28 (48 percent) of the 58 patients without, atrial fibrillation (p less than 0.025). Heart disease was present in 13 (43 percent) of the 30 patients with, versus 15 (26 percent) of the 58 patients without, atrial fibrillation (not significant). Inducible reentrant tachycardia or heart disease, or both, were significant). Inducible reentrant tachycardia or heart disease, or both, were present in 29 (97 percent) of the 30 patients with, versus 34 (59 percent) of the 58 patients without, atrial fibrillation (p less than 0.0005). Of 51 patients with inducible reentrant tachycardia, 23 patients with atrial fibrillation did not differ from 28 patients without this arrhythmia with respect to clinical features and atrial, sinus nodal, or anomalous pathway properties, or cycle length of induced reentrant tachycardia. Spontaneous degeneration of induced reentrant tachycardia to atrial fibrillation was observed in 6 (26 percent) of 23 patients with, versus none of 28 patients without, atrial fibrillation (p less than 0.025). In summary, patients with preexcitation and documented spontaneous paroxysmal atrial fibrillation almost always have inducible reentrant tachycardia or heart disease, or both. It is likely that in many patients with inducible reentrant tachycardia, spontaneously occurring reentrant tachycardia relates to induction of atrial fibrillation. However, it is unclear why some patients with inducible reentrant tachycardia have atrial fibrillation and others do not. In many patients with organic heart disease, atrial fibrillation could relate to hemodynamic changes.

Entities:  

Mesh:

Year:  1981        PMID: 7468492     DOI: 10.1016/0002-9149(81)90539-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  The 12-lead ECG in patients with Mahaim fibers.

Authors:  Eduardo Back Sternick; Luiz Márcio Gerken
Journal:  Ann Noninvasive Electrocardiol       Date:  2006-01       Impact factor: 1.468

2.  Ventricular pre-excitation in the general population: a study on the mode of presentation and clinical course.

Authors:  J A Goudevenos; C S Katsouras; G Graekas; O Argiri; V Giogiakas; D A Sideris
Journal:  Heart       Date:  2000-01       Impact factor: 5.994

3.  Perception and documentation of arrhythmias after successful radiofrequency catheter ablation of accessory pathways.

Authors:  H Oddsson; H Walfridsson; N Edvardsson
Journal:  Ann Noninvasive Electrocardiol       Date:  2001-07       Impact factor: 1.468

4.  Radiofrequency catheter ablation in patients with Wolff-Parkinson-White syndrome.

Authors:  R K Thakur; G J Klein; R Yee
Journal:  CMAJ       Date:  1994-09-15       Impact factor: 8.262

5.  Evaluation of atrial vulnerability immediately after radiofrequency catheter ablation of accessory pathway in patients with Wolff-Parkinson-White syndrome.

Authors:  Kumral Ergun Cagli; Serkan Topaloglu; Dursun Aras; Nihat Sen; Ibrahim Akpinar; Akif Durak; Halil Lutfi Kisacik
Journal:  J Interv Card Electrophysiol       Date:  2009-10-21       Impact factor: 1.900

Review 6.  Wolff-Parkinson-White syndrome. Identification and management.

Authors:  F Gaita; C Giustetto; R Riccardi; A Brusca
Journal:  Drugs       Date:  1992-02       Impact factor: 9.546

7.  Wolff-Parkinson-White syndrome: atrial fibrillation as the presenting arrhythmia.

Authors:  K Robinson; E Rowland; D M Krikler
Journal:  Br Heart J       Date:  1988-05

8.  Atrial electrophysiologic abnormalities in patients with Wolff-Parkinson-White syndrome but without paroxysmal atrial fibrillation.

Authors:  Koichi Sakabe; Nobuo Fukuda; Teru Nada; Hisanori Shinohara; Yoshiyuki Tamura; Tetsuzo Wakatsuki; Akiyoshi Nishikado; Takashi Oki
Journal:  Clin Cardiol       Date:  2004-07       Impact factor: 2.882

9.  Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome.

Authors:  Jasvinder S Sidhu; Yadavendra S Rajawat; Tapan G Rami; Michael H Gollob; Zhinong Wang; Ruiyong Yuan; A J Marian; Francesco J DeMayo; Donald Weilbacher; George E Taffet; Joanna K Davies; David Carling; Dirar S Khoury; Robert Roberts
Journal:  Circulation       Date:  2004-12-20       Impact factor: 29.690

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.